Holen Sie sich die Stockscreener-App
1.63
0.31%
0.005
Handel nachbörslich:
1.63
Schlusskurs vom Vortag:
$1.625
Offen:
$1.63
24-Stunden-Volumen:
39,263
Relative Volume:
0.11
Marktkapitalisierung:
$42.88M
Einnahmen:
$4.99M
Nettoeinkommen (Verlust:
$-28.29M
KGV:
-1.5483
EPS:
-1.0528
Netto-Cashflow:
$-36.20M
1W Leistung:
+1.24%
1M Leistung:
+1.87%
6M Leistung:
+27.34%
1J Leistung:
-14.21%
1-Tages-Spanne:
$1.59
$1.63
1-Wochen-Bereich:
$1.58
$1.64
52-Wochen-Spanne:
$0.8502
$2.00
Lava Therapeutics Nv Stock (LVTX) Company Profile
Firmenname
Lava Therapeutics Nv
Sektor
Branche
Telefon
31 6 3000 3035
Adresse
YALELAAN 62, UTRECHT
Vergleichen Sie LVTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
1.63 | 42.75M | 4.99M | -28.29M | -36.20M | -1.0528 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-10-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-04-19 | Eingeleitet | Jefferies | Buy |
| 2021-04-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Lava Therapeutics Nv Aktie (LVTX) Neueste Nachrichten
How analysts revise price targets for LAVA Therapeutics N.V. (4PKB) stockJuly 2025 Big Picture & Risk Managed Investment Entry Signals - newser.com
Can LAVA Therapeutics N.V. hit a new high this monthTrade Analysis Summary & Technical Confirmation Trade Alerts - newser.com
Will LAVA Therapeutics N.V. stock benefit from green energy trendsBond Market & Weekly Momentum Stock Picks - newser.com
How LAVA Therapeutics N.V. stock valuations compare to rivalsJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
Ranking LAVA Therapeutics N.V. among high performing stocks via toolsTrade Exit Report & Community Consensus Picks - newser.com
Can LAVA Therapeutics N.V. (4PKB) stock expand revenue streamsTrade Entry Report & Reliable Price Breakout Signals - newser.com
Why hedge funds are buying LAVA Therapeutics N.V. stockJuly 2025 Recap & Low Risk Growth Stock Ideas - newser.com
How to track smart money flows in LAVA Therapeutics N.V.Weekly Trade Recap & Breakout Confirmation Alerts - newser.com
Heatmap analysis for LAVA Therapeutics N.V. and competitorsJuly 2025 Closing Moves & Community Verified Trade Signals - newser.com
What indicators show strength in LAVA Therapeutics N.V.July 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com
Is LAVA Therapeutics N.V. showing signs of accumulationJuly 2025 Patterns & Intraday High Probability Setup Alerts - newser.com
Reversal indicators forming on LAVA Therapeutics N.V. stock2025 Volatility Report & Weekly High Return Opportunities - newser.com
Custom strategy builders for tracking LAVA Therapeutics N.V.Swing Trade & Daily Price Action Insights - newser.com
Analyzing LAVA Therapeutics N.V. with risk reward ratio chartsTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com
Advanced analytics toolkit walkthrough for LAVA Therapeutics N.V.Market Growth Report & Stepwise Trade Signal Implementation - newser.com
Historical volatility pattern of LAVA Therapeutics N.V. visualizedWeekly Profit Recap & Verified Trade Idea Suggestions - newser.com
Price momentum metrics for LAVA Therapeutics N.V. explained2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Published on: 2025-10-31 00:32:41 - newser.com
What analysts say about LAVA Therapeutics NV 4PKB stockInsider Trading Activity & Low Cost Portfolio Tips - earlytimes.in
Finanzdaten der Lava Therapeutics Nv-Aktie (LVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):